Hematinics

DBCAT000087Therapeutic category

Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. A DrugBank category of 20 drugs. 20 of them are approved.

Also known as: Erythropoiesis Stimulating Agents · Hematopoietic Agents
Drugs: Darbepoetin alfa
Eltrombopag
Erythropoietin
Ferric derisomaltose
Ferric maltol
Ferric sulfate
Ferrous gluconate
Ferrous succinate
Ferrous sulfate anhydrous
Ferumoxytol
Folic acid
Hydroxocobalamin
Iron Dextran
Iron isomaltoside 1000
Iron polymaltose
Iron protein succinylate
Luspatercept
Methoxy polyethylene glycol-epoetin beta
Pegfilgrastim
Plerixafor

What you can answer from here — as of August 24, 2016

20DrugsEach linked to its full drug card

Listed above

38Drug targetsEvery drug–target pair in the class, with bond type

4,839Marketed productsAcross the regions we cover, with dosage forms and routes

13Routes of administrationHow the drugs in this class are given

Which targets do Hematinics share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account